{
    "schema": 1,
    "fid": "ecnoglutide",
    "type": "article",
    "object_id": 374,
    "title": "Ecnoglutide: Reference Overview and Reconstitution Notes",
    "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
    "url": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide",
    "facts_url": "https://www.preppinpeppers.com/facts/ecnoglutide",
    "currency": null,
    "tldr": "Ecnoglutide (XW003) is an investigational GLP-1 receptor agonist peptide studied in metabolic and weight regulation research. It is not FDA-approved in the US.",
    "facts": [
        {
            "id": "ecnoglutide:title",
            "category": "identity",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "title",
            "value": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:published",
            "category": "identity",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "published",
            "value": "2026-08-15",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:last-reviewed",
            "category": "identity",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "last reviewed",
            "value": "2026-10-05",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:author",
            "category": "identity",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "author",
            "value": "Preppin' Peppers Editorial Team",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:topics",
            "category": "identity",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "topics",
            "value": "Investigational, research",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:summary",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "summary",
            "value": "Ecnoglutide (XW003) is an investigational GLP-1 receptor agonist peptide studied in metabolic and weight regulation research. It is not FDA-approved in the US.",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-1",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What It Is",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-2",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Ecnoglutide",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-3",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What it is",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-4",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Research context and categorization",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-5",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Status",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-6",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Reconstitution notes (general)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-7",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Dilution and handling notes (compound-specific)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-8",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Handling and storage",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-9",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Related reading",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-10",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Tools and supplies",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:section-12",
            "category": "content",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What the research community gets wrong about ecnoglutide",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide"
        },
        {
            "id": "ecnoglutide:product-gansulin-metal-peptide-pen",
            "category": "products",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "references product",
            "value": "Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-metal-peptide-pen"
        },
        {
            "id": "ecnoglutide:product-gansulin-3ml-cartridge",
            "category": "products",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "references product",
            "value": "Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-3ml-cartridge"
        },
        {
            "id": "ecnoglutide:source-pubmed-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Guo et al., Mol Metab 2023: Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/37364710/"
        },
        {
            "id": "ecnoglutide:source-pubchem-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "NCBI PubChem CID 162625103: Ecnoglutide (C194H304N48O61) - pubchem.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://pubchem.ncbi.nlm.nih.gov/compound/162625103"
        },
        {
            "id": "ecnoglutide:source-pmc-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Zhu et al., Nat Commun 2026: Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12881390/"
        },
        {
            "id": "ecnoglutide:source-pubmed-ncbi-nlm-nih-gov-2",
            "category": "source",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Shirley, Drugs 2026: Ecnoglutide: First Approvals - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/42412371/"
        },
        {
            "id": "ecnoglutide:source-pubmed-ncbi-nlm-nih-gov-3",
            "category": "source",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "He et al., Lancet Diabetes Endocrinol 2025: Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/40854315/"
        },
        {
            "id": "ecnoglutide:source-pmc-ncbi-nlm-nih-gov-2",
            "category": "source",
            "entity": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Kumar et al., Endocrinol Diabetes Metab 2026: Comparative Efficacy and Safety of Ecnoglutide in Type 2 Diabetes: A Systematic Review and Meta-Analysis - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13052322/"
        }
    ],
    "buy": [],
    "faq": [
        {
            "q": "What is ecnoglutide (XW003) and how does it work?",
            "a": "Ecnoglutide (XW003) is a long-acting, lipidated GLP-1 receptor agonist from Sciwind Biosciences, built from natural amino acids. Fatty-acid conjugation extends its half-life; it activates the GLP-1 receptor with a cAMP-biased signaling profile."
        },
        {
            "q": "Is ecnoglutide FDA-approved in the United States?",
            "a": "No. Ecnoglutide is investigational and not FDA-approved in the U.S. It has received NMPA marketing approval in China for weight management, but that foreign-market status does not apply to or predict any FDA regulatory action."
        },
        {
            "q": "Is ecnoglutide prohibited in sport under WADA rules?",
            "a": "Ecnoglutide is not specifically named on the WADA Prohibited List. GLP-1 receptor agonists as a class appear on WADA's Monitoring Program—tracked in testing but not currently sanctioned—while the class remains under ongoing review."
        }
    ],
    "jsonld": [
        {
            "@context": "https://schema.org",
            "@type": "Article",
            "headline": "Ecnoglutide: Reference Overview and Reconstitution Notes",
            "url": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide",
            "mainEntityOfPage": "https://www.preppinpeppers.com/blogs/the-lab/ecnoglutide",
            "datePublished": "2026-08-15",
            "dateModified": "2026-10-16",
            "author": {
                "@type": "Person",
                "name": "Preppin' Peppers Editorial Team"
            },
            "publisher": {
                "@type": "Organization",
                "name": "PreppinPeppers"
            },
            "description": "Ecnoglutide (XW003) is an investigational GLP-1 receptor agonist peptide studied in metabolic and weight regulation research. It is not FDA-approved in the US."
        },
        {
            "@context": "https://schema.org",
            "@type": "FAQPage",
            "url": "https://www.preppinpeppers.com/facts/ecnoglutide",
            "mainEntity": [
                {
                    "@type": "Question",
                    "name": "What is ecnoglutide (XW003) and how does it work?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Ecnoglutide (XW003) is a long-acting, lipidated GLP-1 receptor agonist from Sciwind Biosciences, built from natural amino acids. Fatty-acid conjugation extends its half-life; it activates the GLP-1 receptor with a cAMP-biased signaling profile."
                    }
                },
                {
                    "@type": "Question",
                    "name": "Is ecnoglutide FDA-approved in the United States?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "No. Ecnoglutide is investigational and not FDA-approved in the U.S. It has received NMPA marketing approval in China for weight management, but that foreign-market status does not apply to or predict any FDA regulatory action."
                    }
                },
                {
                    "@type": "Question",
                    "name": "Is ecnoglutide prohibited in sport under WADA rules?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Ecnoglutide is not specifically named on the WADA Prohibited List. GLP-1 receptor agonists as a class appear on WADA's Monitoring Program—tracked in testing but not currently sanctioned—while the class remains under ongoing review."
                    }
                }
            ]
        }
    ],
    "dates": {
        "published": "2026-08-15",
        "modified": "2026-10-16"
    }
}